Lakeside Healthcare Research

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Migraine1 trial
• Psoriasis1 trial

Phase

• Phase 21 trial
• Phase 41 trial

Status

• Completed2 trials

Lead sponsor

• Arctic Bioscience1 trial
• Pfizer1 trial

Closed trials

• Completed

  Efficacy and Safety Study of HRO350 in Patients with Mild-to-moderate Psoriasis (the 'HeROPA' Study).

  NCT06125808· Phase 2· Arctic Bioscience· Source

• Completed

  Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens

  NCT05217927· Phase 4· Pfizer· Source